FIB-4 Regression With Direct-Acting Antiviral Therapy in Patients With Hepatitis C Infection: A Safety-Net Hospital Experience
Author:
Publisher
Frontiers Media SA
Subject
General Medicine
Reference34 articles.
1. Hepatitis C: Fact Sheet2019
2. The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?;Goodgame;Am J Gastroenterol.,2003
3. Association between chronic hepatitis C infection and hepatocellular carcinoma;Haydon;Lancet,1995
4. Extrahepatic manifestations of chronic hepatitis C virus infection;Cacoub;Dig Liver Dis.,2014
5. HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters;Kasai;J Hepatol
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Weight Gain and Increased Body Mass Index in Patients with Hepatitis C after Eradication Using Direct-Acting Antiviral Therapy in Taiwan;Diagnostics;2024-01-19
2. Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B;Scientific Reports;2023-06-09
3. HCV direct acting antiviral treatment leads to highly durable rates of ALT and AST lower than 30/19 criteria and improved APRI and FIB ‐4 scores;Hepatology Communications;2022-10-11
4. Assessment of Non-invasive Markers for the Prediction of Esophageal Variceal Hemorrhage;Frontiers in Medicine;2021-12-01
5. Hepatitis C-Induced Hepatocellular Carcinoma in the Middle East;Liver Cancer in the Middle East;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3